In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 2.45 million shares changing hands with its beta currently measuring -1.23. Company’s recent per share price
Candel Therapeutics Inc (NASDAQ:CADL) has a beta value of -1.23 and has seen 0.82 million shares traded in the recent trading session. The company, currently
During the last session, Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares were 0.78 million, with the beta value of the company hitting -1.24. At the end
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 0.74 million during the latest session, with the company’s beta value hitting -1.25. At the last check
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 1.15 million during the last session, with the company’s beta value hitting -1.25. At the close of
In last trading session, Candel Therapeutics Inc (NASDAQ:CADL) saw 0.64 million shares changing hands with its beta currently measuring -1.26. Company’s recent per share price
During the last session, Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares were 0.64 million, with the beta value of the company hitting -1.27. At the end
In the last trading session, 1.01 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) were traded, and its beta was -1.23. Most recently the company’s
In the last trading session, 1.89 million shares of the Candel Therapeutics Inc (NASDAQ:CADL) were traded, and its beta was -1.20. Most recently the company’s
Candel Therapeutics Inc (NASDAQ:CADL)’s traded shares stood at 1.22 million during the last session, with the company’s beta value hitting -1.20. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
